3rd spinal cord injury patient with InVivo's Neuro-Spinal Scaffold improving: 5 key updates


InVivo Therapeutics reported one-month postoperative implant updates for the third patient who underwent surgery for spinal cord injury with the company's Neuro-Spinal Scaffold.

Here are five quick updates:


1. In the month between implantation and follow-up, the patient improved from a complete AIS A spinal cord injury to an incomplete AIS B spinal cord injury. Fewer than 4 percent of patients with high thoracic neurologic level of injury make this conversion in the first month.


2. The patient regained sacral sensation and reported improved bladder function. The second patient treated showed improved sensory function with partial sensation present in five dermatome levels lower on the right side compared to the three month assessment.


3. There weren't any reported serious adverse events associated with the implant.


4. Dom Coric, MD, of Carolina Neurosurgery and Spine Associates implanted both the second and third patients participating in the study trial. The second patient continues to make meaningful progress toward daily living at three months.


5. To date, the Neuro-Spinal Scaffold has been implanted successfully in three consecutive patients without adverse events for either the scaffold or surgical procedure and the company plans to add two more patients to the pilot trial.


"I am very encouraged with the third patient's neurologic recovery following successful implantation of the investigational Neuro-Spinal Scaffold," said William Bockenek, MD, chief medical officer of Carolinas Rehabilitation and co-leader of the study.


Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers